<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Outcome with beta blocker in the long QT syndrome is good in asymptomatic patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Outcome with beta blocker in the long QT syndrome is good in asymptomatic patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Outcome with beta blocker in the long QT syndrome is good in asymptomatic patients</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">During a five-year follow-up of 869 patients with a long QT syndrome, the estimated cumulative probability of experiencing aborted cardiac arrest or death on beta blocker therapy was significantly reduced in those who were asymptomatic (0.97 versus 0.31 events per year on therapy in probands and 0.26 versus 0.15 events per year in affected family members). Recurrent events despite beta blocker therapy were significantly higher in those with a history of syncope (hazard ratio 3.1) or aborted sudden death (hazard ratio 12.9).</div><div class="graphic_reference">Data from Moss AJ, Zareba W, Hall WJ, et al, Circulation 2000; 101:616.</div><div id="graphicVersion">Graphic 78184 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
